Back to News
Market Impact: 0.6

Bernstein lowers Constellation Brands stock price target to $195 on recovery concerns

STZ
Corporate Guidance & OutlookCorporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsConsumer Demand & RetailManagement & Governance
Bernstein lowers Constellation Brands stock price target to $195 on recovery concerns

Constellation Brands (STZ) has experienced significant market pressure, with its stock down over 32% year-to-date and trading near 52-week lows, following substantial cuts to its fiscal year 2026 guidance, including a 4.5 percentage point reduction in beer net sales growth and an approximately 10% cut to EPS. This prompted multiple analyst price target reductions, with Bernstein SocGen lowering its target to $195 from $225 while maintaining an Outperform rating, citing a non-linear recovery path and raising questions about the company's unchanged long-term capacity expansion plans despite current headwinds.

Analysis

Constellation Brands (STZ) is facing significant headwinds, evidenced by a substantial cut to its fiscal year 2026 guidance and a cascade of analyst price target reductions. The company's stock has declined 32.56% year-to-date, trading near its 52-week low, reflecting investor concern over the revised outlook. Management has lowered its beer net sales growth forecast by approximately 4.5 percentage points and its earnings per share guidance by about 10% at the midpoint, attributing the downgrade to a severe 6-7 percentage point inventory headwind expected in Q2, lower volumes, operating deleveraging, and tariffs. In response, firms including Bernstein, BMO Capital, TD Cowen, and Jefferies have all lowered their price targets. Notably, Bernstein, while cutting its target to $195.00, maintains an 'Outperform' rating, suggesting the underlying brands remain strong but that the recovery will be non-linear. A key point of contention raised by analysts is the company's unchanged long-term capital expenditure target of approximately $1.2 billion for FY26 and its capacity expansion goal, which appear misaligned with the sharply reduced near-term growth and profitability projections, posing a risk to future capital allocation efficiency.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.